Comparing Misoprostol and Oxytocin in Uniject for Postpartum Hemorrhage (PPH) Prevention in Senegal

NACompletedINTERVENTIONAL
Enrollment

1,365

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Postpartum Hemorrhage
Interventions
DRUG

Misoprostol

600 mcg misoprostol oral

DEVICE

UnijectTM

10 IU oxytocin delivered intramuscularly with UnijectTM

Trial Locations (1)

Unknown

Health huts in the district of Thiadiaye and Kolda, Thiadiay and Kolda

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

ChildFund International

UNKNOWN

lead

Gynuity Health Projects

OTHER

NCT01713153 - Comparing Misoprostol and Oxytocin in Uniject for Postpartum Hemorrhage (PPH) Prevention in Senegal | Biotech Hunter | Biotech Hunter